Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.05
Data as of 3:59pm ET
 +0.01 / +0.96%
Today’s Change
0.78
Today|||52-Week Range
1.83
-9.48%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$45.9M

Company Description

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. The company engages in the research and development of innovative therapeutics for cancer patients with high unmet medical needs. Its drug-development programs utilize two platforms such as customized PEGylation linker technology and third-generation mRNA-targeting agents utilizing the locked nucleic acid technology. The company receives royalties on marketed products that utilize PEGylation platform, including PegIntron, Sylatron, Macugen, CIMZIA, OMONTYS, Oncaspar and Adagen. Enzon Pharmaceuticals was founded by Abraham Abuchowski on September 17, 1981 and is headquartered in Piscataway, NJ.

Contact Information

Enzon Pharmaceuticals, Inc.
20 Kingsbridge Road
Piscataway New Jersey 08854
P:(732) 980-4500
Investor Relations:

Employees

Shareholders

Other institutional51.00%
Individual stakeholders23.20%
Mutual fund holders10.76%

Top Executives

George W. HebardChief Executive Officer, COO & Secretary
Richard L. FeinsteinChief Financial Officer & Vice President-Finance

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.